Health insurers are finally tackling the prior authorization mess that’s been driving patients and doctors up the wall! America’s Health Insurance Plans announced that major U.S. insurers, covering 257 million people, are rolling out reforms to streamline approvals for medicines and medical services. By standardizing electronic submissions, shrinking the list of procedures needing preapproval, and ensuring 90-day validity across plan switches, they aim to cut delays that fuel 24% of serious patient issues, per AMA surveys. With CVS Health’s Aetna bundling cancer scan approvals and UnitedHealth easing drug reauthorizations, is this a real fix for the $1 trillion healthcare system’s red tape, or just a Band-Aid under pressure from public outrage?

The Reform Rundown

The industry’s trade group, AHIP, laid out a plan to overhaul prior authorization, a process insurers use to control costs but which 90% of physicians say delays care. By early 2027, insurers like Aetna, Cigna, and UnitedHealthcare will adopt standardized data for electronic prior authorization, aiming for 80% real-time approvals when paperwork’s complete. Come early 2026, they’ll shrink the scope of claims needing preapproval, potentially slashing the 50 million annual Medicare Advantage requests by 10%. If patients switch plans mid-treatment, new insurers will honor existing approvals for 90 days, protecting 30% of the 10 million Americans who change coverage yearly.

AHIP’s Mike Tuffin admitted the system’s “fragmented” manual processes spark widespread frustration.

Why It’s a Healthcare Win?

Prior authorization’s a nightmare—24% of doctors link it to serious patient harm, like delayed cancer care, per AMA data. The reforms could save $15 billion over a decade by cutting administrative costs, which eat up 30% of healthcare spending. Patients, like the 1 million with lung cancer needing frequent scans, benefit from Aetna’s bundled approvals for MRI and CT scans, reducing wait times from weeks to days. UnitedHealth’s move to ease reauthorizations for 80 drugs could save 25% of the 5 million annual prescription denials, helping 500,000 patients avoid gaps in therapy. With 257 million covered lives—80% of the U.S. population—these changes could curb the 3.2 million Medicare Advantage denials yearly, boosting access to care.

READ MORE: Flood Risk Update for Swiss Valley After Glacier Collapse in Blatten

How It’s Rolling Out?

Insurers are leaning on tech like FHIR APIs to digitize submissions, targeting 80% real-time responses by 2027, up from 50% today. Aetna’s bundling for cancer patients streamlines 100,000 annual scan requests, while UnitedHealth’s drug reauthorization cuts target generics like statins, used by 30 million Americans. The 90-day continuity rule applies to commercial, Medicare Advantage, and Medicaid plans, impacting 70% of the 180 million privately insured. Insurers must provide clear denial reasons and appeal info, addressing 81% of overturned Medicare Advantage appeals.

Health and Human Services Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz are set to push these reforms, signaling federal oversight to enforce compliance.

The Hurdles Ahead

These reforms aren’t a cure-all. Prior authorization won’t vanish—insurers argue it prevents $100 billion in fraud and overuse, like South Carolina’s $54 million Medicaid spike when preapprovals were lifted. Only 30% of providers use electronic systems now, and 40% of hospitals still rely on faxes, per AHIP, slowing the 2027 tech goal. Aetna’s bundling is limited to three cancers, leaving 1.5 million patients with other types in the lurch. UnitedHealth’s drug reauthorization cuts cover just 80 of 10,000 drugs, and 60% of denials persist due to clinical disputes.

What’s Next?

By 2026, expect 10% fewer prior authorization claims, saving 5 million patients from delays. The 2027 electronic system could process 40 million requests annually, cutting $5 billion in costs. Aetna plans to expand bundled approvals to colon cancer, impacting 200,000 patients, while UnitedHealth eyes 100 more drugs for reauthorization relief. Federal rules, like CMS’s 7-day response mandate for Medicare Advantage, will tighten timelines, potentially saving 1 million tonnes of CO2e via less paper. With 35.6 billion tonnes of global emissions, this is a tiny but tangible step. If Kennedy and Oz push bipartisan bills, like the $4 billion Improving Seniors’ Access Act, 20% of the $1 trillion healthcare market could see faster care.

Explore ESG Solutions on our marketplace - OneStop ESG Marketplace.

Keep abreast of the top ESG Events on OneStop ESG Events.

OneStop ESG Educate: Your go-to source for top ESG courses and training programs tailored to your needs.